We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+14.8%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.85B
AUM Growth
+$181M
Cap. Flow
+$27.3M
Cap. Flow %
1.48%
Top 10 Hldgs %
26.18%
Holding
272
New
16
Increased
74
Reduced
154
Closed
22

Top Buys

Rank Stock Value
1
WEX icon
WEX
WEX
+$25M
2
DOX icon
Amdocs
DOX
+$10.9M
3
ETSY icon
Etsy
ETSY
+$9.39M
4
GNTX icon
Gentex
GNTX
+$8.86M
5
MGPI icon
MGP Ingredients
MGPI
+$6.5M

Top Sells

Rank Stock Value
1
AX icon
Axos Financial
AX
+$16.8M
2
PCRX icon
Pacira BioSciences
PCRX
+$12.5M
3
ADMA icon
ADMA Biologics
ADMA
+$11.5M
4
ACIW icon
ACI Worldwide
ACIW
+$9.89M
5
RXO icon
RXO
RXO
+$8.37M

Sector Composition

Rank Sector Weight
1 Healthcare 30.6%
2 Technology 28.67%
3 Industrials 16.54%
4 Consumer Staples 6.67%
5 Communication Services 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SSTK icon
26
Shutterstock
SSTK
$219M
$18.7M 1.01%
529,387
+153,154
+41% +$5.65M
SUPN icon
27
Supernus Pharmaceuticals
SUPN
$2.77B
$16.9M 0.91%
540,788
+38,202
+8% +$1.19M
BCRX icon
28
BioCryst Pharmaceuticals
BCRX
$2.4B
$16.4M 0.89%
2,163,743
+84,102
+4% +$639K
KNSA icon
29
Kiniksa Pharmaceuticals
KNSA
$5.93B
$16.2M 0.88%
649,630
+49,000
+8% +$1.19M
MMS icon
30
Maximus
MMS
$3.1B
$16.2M 0.88%
173,779
-2,842
-2% -$254K
IOVA icon
31
Iovance Biotherapeutics
IOVA
$2.87B
$15.8M 0.85%
1,679,157
+43,132
+3% +$409K
WIX icon
32
WIX.com
WIX
$2.52B
$15.8M 0.85%
94,285
-3,440
-4% -$553K
CRAI icon
33
CRA International
CRAI
$1.06B
$15.2M 0.82%
86,470
+13,116
+18% +$2.19M
ASPN icon
34
Aspen Aerogels
ASPN
$518M
$14.8M 0.8%
535,113
+88,711
+20% +$2.22M
NGVT icon
35
Ingevity
NGVT
$2.68B
$14.8M 0.8%
379,671
+7,481
+2% +$298K
EOLS icon
36
Evolus
EOLS
$501M
$14.7M 0.79%
904,900
+53,605
+6% +$749K
DOX icon
37
Amdocs
DOX
$6.22B
$14.6M 0.79%
167,023
+128,919
+338% +$10.9M
HROW icon
38
Harrow
HROW
$1.51B
$14.2M 0.77%
314,881
+59,019
+23% +$2M
RBA icon
39
RB Global
RBA
$17.5B
$14M 0.76%
174,044
-6,333
-4% -$514K
POOL icon
40
Pool Corp
POOL
$7.5B
$13.9M 0.75%
36,897
-1,712
-4% -$592K
ITRN icon
41
Ituran Location and Control
ITRN
$1.05B
$13.7M 0.74%
516,699
+72,656
+16% +$1.94M
NBIX icon
42
Neurocrine Biosciences
NBIX
$16.6B
$13.5M 0.73%
117,417
-688
-0.6% -$94.3K
OZK icon
43
Bank OZK
OZK
$5.61B
$13.3M 0.72%
309,351
-13,538
-4% -$576K
ALKS icon
44
Alkermes
ALKS
$8.25B
$12.6M 0.68%
451,657
-16,102
-3% -$429K
LCII icon
45
LCI Industries
LCII
$2.65B
$12.1M 0.66%
100,595
-1,624
-2% -$183K
OABI icon
46
OmniAb
OABI
$447M
$11.5M 0.62%
2,722,321
+163,038
+6% +$705K
ACAD icon
47
Acadia Pharmaceuticals
ACAD
$5.03B
$11M 0.6%
717,146
-25,789
-3% -$430K
CEVA icon
48
CEVA Inc
CEVA
$1.08B
$10.9M 0.59%
452,541
+23,566
+5% +$512K
MTN icon
49
Vail Resorts
MTN
$5.3B
$10.9M 0.59%
62,311
-2,352
-4% -$421K
ETSY icon
50
Etsy
ETSY
$7.85B
$10.6M 0.57%
191,062
+165,508
+648% +$9.39M
1
2
3 4 5

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q3 2024 Portfolio in Review

As of Q3 2024, Rice Hall James & Associates held 272 positions worth $1.85B, up 11% from $1.67B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Rice Hall James & Associates's Q3 2024 filing shows 16 new, 74 increased, 154 reduced and 22 closed positions. Its largest new stake was Gentex: 285,297 shares worth $8.47M. The largest sale was Axos Financial, an estimated $16.8M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 31% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q3 2024 buy was Gentex: 285,297 shares worth $8.47M.
  • Rice Hall James & Associates added most to WEX in Q3 2024, an estimated $25M increase.
  • Rice Hall James & Associates's biggest Q3 2024 reduction was Axos Financial, cutting an estimated $16.8M.
  • Rice Hall James & Associates fully exited RXO in Q3 2024, selling an estimated $8.37M.
  • Rice Hall James & Associates's ten largest holdings make up 26% of its $1.85B portfolio in Q3 2024.
  • Rice Hall James & Associates opened 16 new positions and closed 22 in Q3 2024.
  • Rice Hall James & Associates's portfolio value rose 11% quarter-over-quarter to $1.85B.

Based on Rice Hall James & Associates's 13F filing for Q3 2024, filed 28 Oct 2024.